Clodronate prevents osteolytic breast cancer bone metastases in a mouse model:: Effects on bone mineral density.

被引：0
|
作者：
Käkönen, SM [1 ]
Isaksson, P [1 ]
Lakkakorpi, PT [1 ]
Österman, T [1 ]
Malmström, C [1 ]
Suominen, M [1 ]
Aho, E [1 ]
Sjöholm, B [1 ]
Hokkanen, S [1 ]
Hannuniemi, R [1 ]
机构：
[1] Schering Oy, Preclin R&D, Turku, Finland
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer
    Rizzoli, R
    Forni, M
    Schaad, MA
    Slosman, DO
    Sappino, AP
    Garcia, J
    Bonjour, JP
    BONE, 1996, 18 (06) : 531 - 537
  • [2] Effects of osteolytic bone metastases on bone mass and bone strength in the mouse: Validation of a pre-clinical model of breast cancer metastasis to bone.
    Allen, MJ
    Arrington, SA
    Margulies, BS
    Schoonmaker, JE
    Mann, KA
    Damron, TA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S124 - S124
  • [3] The effect of oral clodronate on bone mineral density in women with primary breast cancer
    Powles, TJ
    McCloskey, E
    Paterson, AHG
    Ashley, S
    Tidy, A
    Kanis, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 344 - 344
  • [4] Statins and bone mineral density.
    Yaturu, S
    Alferos, MG
    Deprisco, C
    Tynes, J
    Wade, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S294 - S294
  • [5] Normalization of bone mineral density.
    Jonasson, K
    Styrkarsdottir, U
    Sigurdsson, G
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S258 - S258
  • [6] CLODRONATE FOR OSTEOLYTIC METASTASES DUE TO BREAST-CANCER
    ELOMAA, I
    BLOMQVIST, C
    PORKKA, L
    HOLMSTROM, T
    TAUBE, T
    LAMBERG-ALLARDT, C
    BORGSTROM, GH
    BIOMEDICINE & PHARMACOTHERAPY, 1988, 42 (02) : 111 - 116
  • [7] Adjuvant clodronate therapy in primary operable breast cancer -: Duration and offset of effects on bone mineral density
    Bal, SK
    Powles, T
    Paterson, S
    Kanis, JA
    Ashley, S
    Tidy, A
    Beneton, M
    Atula, S
    Nevalainen, J
    Pylkkänen, L
    McCloskey, EV
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S10 - S10
  • [8] CLODRONATE IN HYPERCALCEMIA AND OSTEOLYTIC BONE-DISEASE DUE TO BREAST-CANCER
    KANIS, JA
    MCCLOSKEY, EV
    OROURKE, N
    KHAN, S
    FERN, D
    EYRES, K
    SITORI, P
    TAUBE, T
    POWLES, T
    PATERSON, A
    SAUDI MEDICAL JOURNAL, 1993, 14 (02) : 93 - 97
  • [9] Effects of cabozantinib on breast cancer bone metastases, overall survival, and bone mass in a mouse model
    Mohammad, Khalid S.
    Harhash, Ahmed
    John, Sutha K.
    Peng, Xianghong
    Niewolna, Maria
    Murthy, Sreemala
    Laird, A. Douglas
    Aftab, Dana T.
    Guise, Theresa A.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Reduction of visible bone metastases by clodronate therapy in breast cancer
    Tjalma, WA
    Buytaert, PM
    Berneman, ZN
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2001, 22 (03) : 215 - 216
12345